Case Studies

Filters

  • 340B Reform and the Risks to a Hospital-Based Specialty Pharmacy The Request: Capstone advised a client on the potential acquisition of a US company that provides 340B-focused retail and specialty pharmacy management. Our diligence focused on determining the likelihood, rationale, and impact of federal and state 340B reforms to the target company across a dozen specific issues, including: Medicare reimbursement cut for 340B scripts; Commercial […]Learn More
  • Federal Surprise Medical Bill Reform—Team Health and Envision Our Call: Capstone first wrote in December 2018 that federal surprise medical bill legislation—recently introduced in the US Senate—was likely to garner significant momentum in 2019 and pose a meaningful risk to physician staffing companies, particularly those with emergency department exposure such as Team Health Inc. (TMH) and Envision Healthcare Corp. (EVHC). The policy under […]Learn More
  • Emerging Privacy Legislation and its Risks to a Healthcare Tech Company’s Business Model The Request: Capstone advised a client on the potential acquisition of a healthcare analytics company that paired bolstered, value-added overlays to healthcare provider contact data. Specifically, we analyzed regulation, legislation, and other government initiatives that could impact the company. Our diligence paid particular attention to the evolving landscape of amendments to the California Consumer Privacy […]Learn More